Company / Gross Margin
Apyx Medical Corp Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
62.5%
FY2025
5-year range
61.0% / 65.5%
FY2021-FY2025
Trend
+2.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 10 years, ranging from 32.5% in FY2016 to 68.0% in FY2019.
Based on SEC 10-K filings.
62.5% in FY2025 with a 5-year CAGR of -5.1%.
Declined from 65.5% to 62.5% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -2.9pp
- 5-Year Change
- -5.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin increased 2.4% year-over-year.
- Peak gross margin was recorded in FY2019.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 62.5% | +2.4% |
| FY2024 | 61.0% | -6.7% |
| FY2023 | 65.5% | +0.0% |
| FY2022 | 65.5% | +3.6% |
| FY2021 | 63.2% | -6.6% |
| FY2020 | 67.6% | -0.5% |
| FY2019 | 68.0% | +17.2% |
| FY2018 | 58.0% | +36.4% |
| FY2017 | 42.5% | +31.0% |
| FY2016 | 32.5% | -16.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026